Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products

Author(s):  Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy

Issue:  Nov/Dec 2014 - Volume 18, Number 6
View All Articles in Issue

Page(s):  520-525

High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 1
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 2
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 3
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 4
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 5
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 6

Download in electronic PDF format for $65

Abstract:  The compounding and evaluation of ondansetron hydrochloride dihydrate topical gel, 2.5% w/w, were conducted in this study. The gelling agent was Carbopol 940. Ethanol 70% in purified water was used to dissolve the drug and disperse the gelling agent. A gel was formed by adding drops of 0.1 N sodium hydroxide solution. To assay this gel, we developed a simple and reproducible stabilityindicating high-performance liquid chromatographic method. This method was validated for specificity, accuracy, and precision. The compounded gel was assayed in triplicate, and the average recovery was 98.3%. Ondansetron marketed products were analyzed for comparison with the compounded formulation. Assay, accuracy, and precision data of the compounded topical gel were comparable to the marketed products.

Related Keywords: Masuda Quamrun, PhD, RPh, Rashid Mamoon, PhD, Shams Nasheed, MD, Mullins Randy, PharmD, FASCP, ondansetron hydrochloride dihydrate, topical preparations, Carbopol 940, antiemetic, nausea, vomiting, serotonin 5-HT3 receptor antagonist, 5-HT3 blocker, formulations, HPLC assay development

Related Categories: CANCER AND AIDS, EXCIPIENTS, PEER-REVIEWED, QUALITY CONTROL, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Quamrun Masuda
, Mamoon Rashid, Nasheed Shams, Mullins Randy
Nov/Dec 2014
Pg. 520-525

Ondansetron Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 339

Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation
Rashid Mamoon
, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy
May/Jun 2019
Pg. 250-257

A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies
Hall Essence
, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal
May/Jun 2021
Pg. 197-204

Granisetron 1-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 66

Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Wu George
, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Jan/Feb 2018
Pg. 86-94

Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig
, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 156-160

Nausea and Vomiting in Hospice Patients
Boomsma Diane
Jul/Aug 2000
Pg. 250-251

Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C
, Ben Michel, Trusley Craig, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173

Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Wu George
, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018
Pg. 76-85